Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Government regulations

3.3.1. U.S. FDA
3.3.2. Europe CE mark
3.3.3. Ministry of Health, Labor, and Welfare (MHLW)

3.4. Reimbursement scenarios
3.5. Clinical trials
3.6. Patent analysis

3.6.1. U.S. patent analysis, by market participant
3.6.2. Europe patent analysis, by market participant
3.6.3. China patent analysis, by market participant
3.6.4. Canada patent analysis, by market participant
3.6.5. Japan patent analysis by market participant
3.6.6. Other countries patent analysis, by market participant

3.7. Top impacting factors
3.8. Market Dynamics

3.8.1. Drivers

3.8.1.1. Rise in the prevalence of lifestyle diseases
3.8.1.2. Increase in the geriatric population
3.8.1.3. Rise in the adoption rate of remote patient monitoring devices

3.8.2. Restrains

3.8.2.1. Government regulations and reimbursement issues
3.8.2.2. Limited awareness and high costs

3.8.3. Opportunities

3.8.3.1. Untapped markets in developing countries
3.8.3.2. Technological advancements

Chapter: 4: PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Hemodynamic monitoring devices

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Blood glucose monitors

4.2.4.1. Market size and forecast

4.2.5. Blood gas and electrolyte analyzers/monitors

4.2.5.1. Market size and forecast

4.2.6. Blood pressure monitors

4.2.6.1. Market size and forecast

4.3. Neuromonitoring devices

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Electroencephalograph (EEG) devices

4.3.4.1. Market size and forecast

4.3.5. Transcranial dopplers (TCD)

4.3.5.1. Market size and forecast

4.3.6. Magnetoencephalograph (MEG) devices

4.3.6.1. Market size and forecast

4.3.7. Intracranial pressure monitors (ICP)

4.3.7.1. Market size and forecast

4.3.8. Cerebral oximeters

4.3.8.1. Market size and forecast

4.4. Cardiac monitoring devices

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Electrocardiogram (ECG) devices

4.4.4.1. By type
4.4.4.2. By lead type
4.4.4.3. Market size and forecast

4.4.5. Holter monitors

4.4.5.1. Market size and forecast

4.4.6. Event monitors

4.4.6.1. By type
4.4.6.2. By technology
4.4.6.3. Market size and forecast

4.4.7. Others (Implantable loop recorder, Cardiac output monitor and others)

4.4.7.1. Market size and forecast

4.5. Fetal and neonatal monitoring devices

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Ultrasound

4.5.4.1. Market size and forecast

4.5.5. Electronic Fetal Monitoring Devices

4.5.5.1. Market size and forecast

4.5.6. Fetal Doppler Monitoring Devices

4.5.6.1. Market size and forecast

4.5.7. Other Fetal and Neonatal Monitoring Devices

4.5.7.1. Market size and forecast

4.6. Respiratory monitors

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Capnographs

4.6.4.1. Market size and forecast

4.6.5. Pulse oximeters

4.6.5.1. Market size and forecast

4.6.6. Sleep apnea monitors

4.6.6.1. Market size and forecast

4.6.7. Spirometers

4.6.7.1. Market size and forecast

4.7. Multiparameter monitoring devices

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. High acuity

4.7.4.1. Market size and forecast

4.7.5. Mid acuity

4.7.5.1. Market size and forecast

4.7.6. Low acuity

4.7.6.1. Market size and forecast

4.8. Remote patient monitoring devices

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

4.9. Weight monitoring devices

4.9.1. Key market trends
4.9.2. Key growth factors and opportunities
4.9.3. Market size and forecast

4.10. Temperature monitoring devices

4.10.1. Key market trends
4.10.2. Key growth factors and opportunities
4.10.3. Market size and forecast

4.11. Urine output monitoring

4.11.1. Key market trends
4.11.2. Key growth factors and opportunities
4.11.3. Market size and forecast

Chapter: 5: PATIENT MONITORING DEVICES MARKET, BY END USER

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Market size and forecast

5.3. Home settings

5.3.1. Market size and forecast

5.4. Ambulatory surgical centers (ASC)

5.4.1. Market size and forecast

Chapter: 6: PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Market size and forecast

6.2.1.1. U.S. market size and forecast
6.2.1.2. Canada market size and forecast
6.2.1.3. Mexico market size and forecast

6.3. Europe

6.3.1. Market size and forecast

6.3.1.1. Germany market size and forecast
6.3.1.2. France market size and forecast
6.3.1.3. UK market size and forecast
6.3.1.4. Italy market size and forecast
6.3.1.5. Spain market size and forecast
6.3.1.6. Rest of Europe market size and forecast

6.4. Asia-Pacific

6.4.1. Market size and forecast

6.4.1.1. Japan market size and forecast
6.4.1.2. China market size and forecast
6.4.1.3. Australia market size and forecast
6.4.1.4. India market size and forecast
6.4.1.5. South Korea market size and forecast
6.4.1.6. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Market size and forecast

6.5.1.1. Brazil market size and forecast
6.5.1.2. Turkey market size and forecast
6.5.1.3. Venezuela market size and forecast
6.5.1.4. Saudi Arabia market size and forecast
6.5.1.5. Rest of LAMEA market size and forecast

Chapter: 7: COMPANY PROFILES

7.1. Abbott Laboratories

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. Biotronik SE & Co. KG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments

7.3. General Electric Company (GE Healthcare)

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. F. Hoffmann-La Roche Ltd.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. Johnson & Johnson

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. Koninklijke Philips N.V. (Philips Healthcare)

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments

7.7. Masimo Corporation

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Product portfolio
7.7.4. Business performance
7.7.5. Key Strategic Moves:

7.8. Medtronic Plc. (Covidien Ltd.)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Nihon Kohden Corporation

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. Omron Corporation

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key Strategic Moves: